Compare · OPRX vs V
OPRX vs V
Side-by-side comparison of OptimizeRx Corporation (OPRX) and Visa Inc. (V): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPRX and V operate in Real Estate (Real Estate), so they compete in similar markets.
- V is the larger of the two at $679.28B, about 5410.9x OPRX ($125.5M).
- Over the past year, OPRX is down 47.9% and V is up 2.1% - V leads by 50.0 points.
- V has been more active in the news (13 items in the past 4 weeks vs 1 for OPRX).
- V has more recent analyst coverage (25 ratings vs 11 for OPRX).
- Company
- OptimizeRx Corporation
- Visa Inc.
- Price
- $6.71+0.75%
- $358.51-1.72%
- Market cap
- $125.5M
- $679.28B
- 1M return
- +27.08%
- +7.59%
- 1Y return
- -47.90%
- +2.14%
- Industry
- Real Estate
- Real Estate
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 13
- Recent ratings
- 11
- 25
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
Visa Inc.
Visa Inc. operates as a payments technology company worldwide. The company facilitates digital payments among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. In addition, the company offers card products, platforms, and value-added services. It provides its services under the Visa, Visa Electron, Interlink, VPAY, and PLUS brands. The company was founded in 1958 and is headquartered in San Francisco, California.
Latest OPRX
- OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
- OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
- OptimizeRx Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Klema Cathy was granted 34,517 shares, increasing direct ownership by 160% to 56,137 units (SEC Form 4)
- Director Lang James Paul was granted 34,517 shares, increasing direct ownership by 9% to 433,837 units (SEC Form 4)
- Director Presti Mariyamma Varghese was granted 17,258 shares, increasing direct ownership by 132% to 30,318 units (SEC Form 4)
- Director Spangler Patrick D was granted 34,517 shares, increasing direct ownership by 78% to 78,732 units (SEC Form 4)
- Director Vos Ellen O'Connor was granted 34,517 shares, increasing direct ownership by 48% to 107,159 units (SEC Form 4)
- Director Wasson Gregory D was granted 34,517 shares, increasing direct ownership by 60% to 91,700 units (SEC Form 4)
- Director Presti Mariyamma Varghese was granted 13,060 shares (SEC Form 4)
Latest V
- Visa Introduces Platform for Stablecoin Minting, Movement and Management
- Visa Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Thredd Joins The Visa Agentic Ready Programme, Bringing Agent Network Readiness To Issuers Across Europe, Starting With Zilch
- Visa Introduces AI Financial Assistant, Helping Banks Guide Customers from Insight to Action
- Barclays initiated coverage on Visa with a new price target
- Visa Research: The Great Wealth Transfer Is Already Reshaping How Americans Spend
- Visa to Announce Fiscal Third Quarter 2026 Financial Results on July 28, 2026
- GENERAL COUNSEL Rottenberg Julie B exercised 2,027 shares at a strike of $109.82 and sold $729,720 worth of shares (2,027 units at $360.00) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Executive Officer Mcinerney Ryan exercised 10,490 shares at a strike of $109.82 and sold $3,608,434 worth of shares (10,490 units at $343.99) as part of a pre-agreed trading plan (SEC Form 4)
- Kyivstar Subsidiary Uklon Launches Visa Acceptance Platform, Strengthening Digital Payments Infrastructure in Ukraine